BBBen W. R. Balzer

Ben W. R. Balzer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ben W. R. Balzer has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Katharine S. Steinbeck

    Affiliations Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW, Australia, Specialty of Child and Adolescent Health, The Children’s Hospital at Westmead Clinical School, Sydney, NSW, Australia

    5 shared publications
  • Karen Paxton

    University of Sydney, Sydney Medical School, School of Rural Health, Orange and Dubbo, New South Wales, Australia

    4 shared publications
  • Katharine Steinbeck

    Children's Hospital Westmead Clinical School, The University of Sydney, Westmead, New South Wales, Australia

    4 shared publications
  • David J. Handelsman

    Affiliation Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW, Australia

    3 shared publications
  • Georgina Luscombe

    School of Rural Health Dubbo/Orange, The University of Sydney, Orange, NSW, Australia

    3 shared publications
  • Antoinette Anazodo

    Kids Cancer Centre Sydney Children's Hospital Randwick New South Wales Australia

    2 shared publications

Latest Publications

  • Fabricated or Induced Illness in Children: Experience of a Tertiary Australian Children's Hospital

    by Sandra Hanna, Ben W. R. Balzer, Lydia J. Garside

    Aims: Fabricated or Induced Illness in Children (FIIC) is a complex form of child abuse. Harm to the child is both iatrogenic and psychological, driven by caregivers. Our aim was to characterise the clinical features and outcomes of FIIC cases in a tertiary Australian child protection unit (CPU). Methods: Retrospective review of cases referred for concerns of FIIC over a 15‐year period from 1 January 2006 to 31 December 2020. Cases were excluded if they did not meet the Royal College of Paediatrics and Child Health (RCPCH) definition of FIIC or if there was inadequate information available. Results: Twenty‐two referrals fulfilled the criteria for diagnosis of FIIC, constituting 0.23% of all referrals for physical abuse and neglect. There was a 4‐year duration between first presentation and first concern for FIIC being raised. Indirect evidence of FII was identified in 95% of cases, and only one case had direct evidence in the form of laboratory proof of poisoning. Additional child protection concerns were identified in 36% of cases. Statutory child protection reporting was made in most cases (77%). In 65% of the total cases, the child remained with the carer, who continued to seek excessive medical care—all were cases of indirect FIIC. Conclusions: Children with indirect evidence of FIIC are at risk of further harm through unnecessary and extensive medical investigations. Statutory agency intervention is often required, and further research is needed to identify effective multi‐agency management strategies.


  • Open Access

    Association of urinary sex hormones with mood and behavior changes in a community adolescent cohort

    by Philip Hazell, Ben W. R. Balzer, Frances Garden, David J. Handelsman, Karen Paxton, Catherine Hawke, Rebecca Ivers, S. Rachel Skinner, Georgina Luscombe, Katharine S. Steinbeck

    Objective: To examine the contribution of variation in sex hormone excretion to mood and behavioral changes in adolescent females and males. Design: Prospective, longitudinal observational cohort study. Methods: Participants were 342 volunteers aged 10–12 years living in rural Australia. Urinary estradiol and testosterone levels measured by liquid chromatography-mass spectrometry were obtained at three-month intervals for three years. Integrated measures (area-under-curve) of urinary steroid excretion summarised as absolute and variability during each 12-month period of the study. Psychosocial data were gathered annually with the primary outcome of depressive symptomatology. Secondary outcomes were the other subscales of the Youth Self-Report, impulsive-aggression, sleep habits, and self-harm. Results: 277 (158 male) participants contributed data over the full duration of the study and could be included in the analyses. In females, analyses of absolute urine hormone levels found no relationship between estradiol and any outcome, but higher testosterone was significantly associated with depression and poorer sleep. Greater variability of both urine estradiol and testosterone was associated with lower total psychopathology, anxious/depressed and social problems scores. Greater variability in urine estradiol was associated with lower attention problems and impulsive aggression in females. In males, higher testosterone and estradiol levels were associated with rule-breaking, and poorer sleep, and no associations were found for gonadal hormone variability for males. Conclusions: Longitudinal measurement of both iso-sexual and contra-sexual gonadal hormones contributes to a more nuanced view of the impact of sex steroids on mood and behavior in adolescents. These findings may enlighten the understanding of the impact of sex steroids during normal male and female puberty with implications for hormone replacement therapies as well as management of common mood and behavioral problems.


  • Foot Length Growth as a Novel Marker of Early Puberty

    by Ben W. R. Balzer, Hoi Lun Cheng, Frances Garden, Georgina M. Luscombe, Karen T. Paxton, Catherine I. Hawke, David J. Handelsman, Katharine S. Steinbeck

    Foot growth is part of overall pubertal growth but its relation to other anthropometric and hormonal changes is unclear. Our objective was to determine how foot length changes relate to changes in other growth parameters (height and weight), Tanner stage, and serum hormones. Adolescents (n = 342) were recruited to a 3-year longitudinal cohort study, underwent annual anthropometric assessments (height, weight, and foot length), and provided self-rated Tanner staging. They also provided blood samples that were analyzed using liquid chromatography-tandem mass spectrometry for serum testosterone and estradiol and classified as pre-pubertal or pubertal based on circulating hormone levels. Average annual percent increase in foot length was greater for pre-pubertal adolescents compared with pubertal. Increased foot length was associated with increases in height, weight, Tanner stage, and serum hormones in males and pre-menarcheal females but not post-menarcheal females. Foot length offers a novel, noninvasive, cost-effective, and easily demonstrable marker of early pubertal changes.


  • Self-rated Tanner stage and subjective measures of puberty are associated with longitudinal gonadal hormone changes

    by Ben W.R. Balzer, Frances L. Garden, Mazen Amatoury, Georgina M. Luscombe, Karen Paxton, Catherine I. Hawke, David J. Handelsman, Katharine S. Steinbeck

    Introduction: In large community-based studies of puberty, Tanner staging by a clinician is often not possible. We compared self-rated Tanner staging and other subjective ratings of pubertal development with serum hormone levels measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) to reassess the utility of self-rated pubertal stage using highly sensitive and specific hormone analysis. Methods: Adolescents and their parents enrolled in the Adolescent Rural Cohort study of Hormones and health, Education, environments and Relationships (ARCHER) answered annual survey questions on pubertal development. Annually, adolescents provided blood samples for serum testosterone and estradiol measured by LC-MS/MS. Results: Longitudinally, self-rated Tanner stage was positively associated with serum testosterone and estradiol levels in both sexes. Confirmation by adolescent and parent that puberty had commenced was associated with higher gonadal hormone levels in both sexes. Parent and adolescent responses demonstrated ‘fair’ to ‘moderate’ agreement. Conclusions: Over a 3-year follow-up, self-rated Tanner staging and simple questions regarding pubertal onset and development are positively associated with adolescent gonadal hormone concentrations in serum measured by mass spectrometry. Thus, self-report of puberty stage still has a role in large community-based studies where physical examination is not feasible.


  • Open Access

    Visual Acuity Improves in Children and Adolescents With Idiopathic Infantile Nystagmus

    by Ben W R Balzer, Caroline J Catt, Milia Bou-Abdou, Frank J Martin

    The Asia-Pacific Journal of Ophthalmology (APJO) is the official publication of the Asia-Pacific Academy of Ophthalmology. The APJO positions itself as a first-class bimonthly (6 issues per year) peer-viewed e-journal representative of ophthalmic and visual science developments in the Asia-Pacific region. The APJO welcomes the submission of original, previously unpublished manuscripts which describe clinical investigations, clinical observations and clinically relevant laboratory investigations.


  • Adenocarcinoma of the Lung in Childhood and Adolescence: A Systematic Review

    by Ben W.R. Balzer, Christine Loo, Craig R. Lewis, Toby N. Trahair, Antoinette C. Anazodo


  • Alectinib is effective, safe and tolerable in an adolescent with stage IVB ALK-rearranged adenocarcinoma of the lung

    by Ben W.R. Balzer, Christine Loo, Eva A. Wegner, Christa E. Nath, Samiuela Lee, Chantelle Smith, Craig R. Lewis, Toby N. Trahair, Antoinette C. Anazodo

    Anaplastic lymphoma kinase (ALK) inhibitors such as crizotinib and alectinib have been shown to have significant activity in ALK-rearranged non-small cell lung cancers (NSCLC). There are no data for alectinib’s safety or efficacy in younger patients, though it is superior to crizotinib in adult trials. We present a 14-year old girl diagnosed with stage IV-B ALK-positive adenocarcinoma of the lung after presenting with cough and fever. She was commenced on alectinib at adult dose and has had sustained complete metabolic remission for 9 months. She is the youngest patient with lung adenocarcinoma to be treated with alectinib.


  • Open Access

    Urinary Sex Steroids and Anthropometric Markers of Puberty - A Novel Approach to Characterising Within-Person Changes of Puberty Hormones

    by Gurmeet K S Singh, Ben W R Balzer, Patrick J Kelly, Karen Paxton, Catherine I Hawke, David J Handelsman, Katharine S Steinbeck

    The longitudinal relationships of within-individual hormone and anthropometric changes during puberty have not ever been fully described. The objectives of this study were to demonstrate that 3 monthly urine collection was feasible in young adolescents and to utilise liquid chromatography-tandem mass spectrometry assay methods for serum and urine testosterone (T), estradiol (E2) and luteinizing hormone (LH) in adolescents by relating temporal changes in urine and serum hormones over 12 months to standard measures of pubertal development. A community sample of 104 adolescents (57 female) was studied over 12 months with annual anthropometric assessment, blood sampling and self-rated Tanner staging and urine collected every 3 months. Serum and urine sex steroids (T, E2) were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and LH by immunoassay. A high proportion (92%) of scheduled samples were obtained with low attrition rate of 6.7% over the 12 months. Urine hormone measurements correlated cross-sectionally and longitudinally with age, anthropometry and Tanner stage. We have developed a feasible and valid sampling methodology and measurements for puberty hormones in urine, which allows a sampling frequency by which individual pubertal progression in adolescents can be described in depth.


  • The effects of estradiol on mood and behavior in human female adolescents: a systematic review

    by Ben W. R. Balzer, Sally-Anne Duke, Catherine I. Hawke, Katharine S. Steinbeck

    Mood disorders and health risk behaviors increase in adolescence. Puberty is considered to contribute to these events. However, the precise impact of pubertal hormone changes to the emergence of mood disorders and risk behaviors is relatively unclear. It is important that inappropriate attribution is not made. Our aim was to determine what is known about the effect of endogenous estradiol on human adolescent girls’ mood and behavior. The databases searched were MEDLINE, Embase, PsycINFO, Education Resources Information Center (ERIC), Pre-MEDLINE, Web of Science, and Scopus for all dates to October 2014. For inclusion, contemporaneous hormone and mood or behavioral assessment was required. Data were extracted following a template created by the authors. Fourteen studies met our inclusion criteria. There was some consistency in findings for mood and estradiol levels, with associations between estradiol and depression and emotional tone and risk taking. Results were less consistent for studies assessing other mood and behavioral outcomes. Most studies were cross-sectional in design; assay methodologies used in older studies may lack the precision to detect early pubertal hormone levels. Conclusion: Three longitudinal and several cross-sectional studies indicate potential associations between estradiol and certain mood or affective states, especially depression and mood variability though there are insufficient data to confirm that the rise in estradiol during puberty is causative. We believe that it is important for health professionals to take care when attributing adolescent psychopathology to puberty hormones, as the current data supporting these assertions are limited.